Search results for “Neuroendocrine Cancer” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 104 patents, we discovered top 37 key players by total patent application. OBI Pharma, Inc., Novartis AG, Oxford BioTherapeutics Ltd. are dominant in this area. They take 26.92% of the total patent filing.
OBI Pharma, Inc.
Taiwan Province, China
Patent: 12
Novartis AG
Basel-Stadt, Switzerland
Patent: 8
Oxford BioTherapeutics Ltd.
YORK COUNTY, United Kingdom
Patent: 8
Infinity Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 5
Advanced Accelerator Applications SA
France
Patent: 4
Biotheranostics, Inc.
California, United States
Patent: 4
Amgen, Inc.
California, United States
Patent: 3
Regents of the University of California
California, United States
Patent: 3
Ipsen Bioinnovation Ltd.
United Kingdom
Patent: 3
STARTUP
Elypta AB
Sweden
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 7 patents, we discovered top 3 start-ups by total patent application.
STARTUP
Elypta AB
Sweden
Patent: 3
STARTUP
Metabomed Ltd.
Israel
Patent: 2
Tempus Labs, Inc.
Illinois, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 61 patents applied in the last 5 years. We discover 30 most active companies in this area. The fast-growing Oxford BioTherapeutics Ltd., Xylonix IP Holdings Pte Ltd, OBI Pharma, Inc. take 26.23% of patent filing during this period.
Oxford BioTherapeutics Ltd.
YORK COUNTY, United Kingdom
Patent: 8
Xylonix IP Holdings Pte Ltd
undefined undefined
Patent: 4
OBI Pharma, Inc.
Taiwan Province, China
Patent: 4
4D Pharma Research Ltd.
Aberdeen City, United Kingdom
Patent: 3
STARTUP
Elypta AB
Sweden
Patent: 3
UAB Research Foundation
Alabama, United States
Patent: 3
STARTUP
Metabomed Ltd.
Israel
Patent: 2
Curium US LLC
United States
Patent: 2
Quest Diagnostics Investments LLC
New Jersey, United States
Patent: 2
SomScan ApS
Denmark
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 61 patents in last 5 years, we discover 24 new entrants. Oxford BioTherapeutics Ltd., Xylonix IP Holdings Pte Ltd, 4D Pharma Research Ltd. are the most active new entrants in this area.
Oxford BioTherapeutics Ltd.
YORK COUNTY, United Kingdom
Patent: 8
Xylonix IP Holdings Pte Ltd
undefined undefined
Patent: 4
4D Pharma Research Ltd.
Aberdeen City, United Kingdom
Patent: 3
UAB Research Foundation
Alabama, United States
Patent: 3
STARTUP
Elypta AB
Sweden
Patent: 3
SomScan ApS
Denmark
Patent: 2
STARTUP
Metabomed Ltd.
Israel
Patent: 2
Curium US LLC
United States
Patent: 2
Quest Diagnostics Investments LLC
New Jersey, United States
Patent: 2
Assistance Publique des Hôpitaux de Paris SA
France
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 32 patents, we discovered top 7 universities and scientific research institutions by total patent application. Dartmouth College, Philipps University of Marburg, Baylor College of Medicine are dominant in this area. They take 56.25% of the total patent filing.
Dartmouth College
New Hampshire, United States
Patent: 9
Philipps University of Marburg
Hessen, Germany
Patent: 2
Baylor College of Medicine
Texas, United States
Patent: 2
Georgetown University School of Medicine
District of Columbia, United States
Patent: 2
Imperial College London
United Kingdom
Patent: 1
Université de Paris 5 René Descartes
France
Patent: 1
Ocean University of China
Shandong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: